Author's replyBMJ 2003; 327 doi: https://doi.org/10.1136/bmj.327.7416.683 (Published 18 September 2003) Cite this as: BMJ 2003;327:683
- Philip C Calder, professor of nutritional immunology (firstname.lastname@example.org)
- Institute of Human Nutrition, University of Southampton, Southampton SO16 7PX
EDITOR—In my editorial I said that the benefits of immunonutrition identified in meta-analyses are more pronounced in surgical than critically ill patients and that doubts remain about the efficacy of this approach in critically ill patients. I concluded that use of immunonutrition should be approached cautiously in most critically ill patients.
In addition, I highlighted that one trial …